Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases.

Pinheiro Dos Santos MJC, Bastos AU, da Costa VR, Delcelo R, Lindsey SC, Colozza-Gama GA, Peng H, Rauscher FJ 3rd, Oler G, Cerutti JM.

Endocr Pathol. 2018 Sep;29(3):222-230. doi: 10.1007/s12022-018-9526-7.

PMID:
29560564
2.

Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene.

Montero-Conde C, Leandro-Garcia LJ, Chen X, Oler G, Ruiz-Llorente S, Ryder M, Landa I, Sanchez-Vega F, La K, Ghossein RA, Bajorin DF, Knauf JA, Riordan JD, Dupuy AJ, Fagin JA.

Proc Natl Acad Sci U S A. 2017 Jun 20;114(25):E4951-E4960. doi: 10.1073/pnas.1702723114. Epub 2017 Jun 5.

3.

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

Shi X, Liu R, Basolo F, Giannini R, Shen X, Teng D, Guan H, Shan Z, Teng W, Musholt TJ, Al-Kuraya K, Fugazzola L, Colombo C, Kebebew E, Jarzab B, Czarniecka A, Bendlova B, Sykorova V, Sobrinho-Simões M, Soares P, Shong YK, Kim TY, Cheng S, Asa SL, Viola D, Elisei R, Yip L, Mian C, Vianello F, Wang Y, Zhao S, Oler G, Cerutti JM, Puxeddu E, Qu S, Wei Q, Xu H, O'Neill CJ, Sywak MS, Clifton-Bligh R, Lam AK, Riesco-Eizaguirre G, Santisteban P, Yu H, Tallini G, Holt EH, Vasko V, Xing M.

J Clin Endocrinol Metab. 2016 Jan;101(1):264-74. doi: 10.1210/jc.2015-2917. Epub 2015 Nov 3.

4.

NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition.

Garcia-Rendueles ME, Ricarte-Filho JC, Untch BR, Landa I, Knauf JA, Voza F, Smith VE, Ganly I, Taylor BS, Persaud Y, Oler G, Fang Y, Jhanwar SC, Viale A, Heguy A, Huberman KH, Giancotti F, Ghossein R, Fagin JA.

Cancer Discov. 2015 Nov;5(11):1178-93. doi: 10.1158/2159-8290.CD-15-0330. Epub 2015 Sep 10. Erratum in: Cancer Discov. 2019 Nov;9(11):1628.

5.

BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma.

Bastos AU, Oler G, Nozima BH, Moysés RA, Cerutti JM.

Eur J Endocrinol. 2015 Oct;173(4):525-40. doi: 10.1530/EJE-15-0254.

PMID:
26338373
6.

ABI3 ectopic expression reduces in vitro and in vivo cell growth properties while inducing senescence.

Latini FR, Hemerly JP, Freitas BC, Oler G, Riggins GJ, Cerutti JM.

BMC Cancer. 2011 Jan 11;11:11. doi: 10.1186/1471-2407-11-11.

7.

PVALB, a new Hürthle adenoma diagnostic marker identified through gene expression.

Cerutti JM, Oler G, Delcelo R, Gerardt R, Michaluart P Jr, de Souza SJ, Galante PA, Huang P, Riggins GJ.

J Clin Endocrinol Metab. 2011 Jan;96(1):E151-60. doi: 10.1210/jc.2010-1318. Epub 2010 Oct 6.

8.
10.

Neuromodulatory property of standardized extract Ginkgo biloba L. (EGb 761) on memory: behavioral and molecular evidence.

Oliveira DR, Sanada PF, Saragossa Filho AC, Innocenti LR, Oler G, Cerutti JM, Cerutti SM.

Brain Res. 2009 May 7;1269:68-89. doi: 10.1016/j.brainres.2008.11.105. Epub 2008 Dec 29.

PMID:
19146837
11.

Down-regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment.

Camacho CP, Latini FR, Oler G, Hojaij FC, Maciel RM, Riggins GJ, Cerutti JM.

Clin Endocrinol (Oxf). 2009 Mar;70(3):475-83. doi: 10.1111/j.1365-2265.2008.03349.x. Epub 2008 Aug 22.

12.

Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis.

Oler G, Camacho CP, Hojaij FC, Michaluart P Jr, Riggins GJ, Cerutti JM.

Clin Cancer Res. 2008 Aug 1;14(15):4735-42. doi: 10.1158/1078-0432.CCR-07-4372.

13.

Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion.

Latini FR, Hemerly JP, Oler G, Riggins GJ, Cerutti JM.

Endocr Relat Cancer. 2008 Sep;15(3):787-99. doi: 10.1677/ERC-08-0079. Epub 2008 Jun 17.

14.

Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis.

Cerutti JM, Oler G, Michaluart P Jr, Delcelo R, Beaty RM, Shoemaker J, Riggins GJ.

Cancer Res. 2007 Aug 15;67(16):7885-92.

15.

Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis.

Oler G, Ebina KN, Michaluart P Jr, Kimura ET, Cerutti J.

Clin Endocrinol (Oxf). 2005 Apr;62(4):509-11. No abstract available.

PMID:
15807885

Supplemental Content

Support Center